KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other financing activities (2016 - 2024)

Historic Other financing activities for West Pharmaceutical Services (WST) over the last 14 years, with Q1 2024 value amounting to -$100000.0.

  • West Pharmaceutical Services' Other financing activities changed N/A to -$100000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was -$100000.0, marking a year-over-year decrease of 20000.0%. This contributed to the annual value of $1.2 million for FY2022, which is N/A changed from last year.
  • West Pharmaceutical Services' Other financing activities amounted to -$100000.0 in Q1 2024.
  • In the past 5 years, West Pharmaceutical Services' Other financing activities registered a high of $2.3 million during Q4 2020, and its lowest value of -$100000.0 during Q4 2022.
  • In the last 3 years, West Pharmaceutical Services' Other financing activities had a median value of $200000.0 in 2022 and averaged $680000.0.
  • The largest annual percentage gain for West Pharmaceutical Services' Other financing activities in the last 5 years was 38750.0% (2020), contrasted with its biggest fall of 38750.0% (2020).
  • West Pharmaceutical Services' Other financing activities (Quarter) stood at $2.3 million in 2020, then plummeted by 104.35% to -$100000.0 in 2022, then changed by 0.0% to -$100000.0 in 2024.
  • Its last three reported values are -$100000.0 in Q1 2024, -$100000.0 for Q4 2022, and $200000.0 during Q2 2022.